Compounded semaglutide · 12-month plan · $828 up front · checked Oct 16
Check price for EmbodyOn Embody's site · partner link
Comparison · updated October 17, 2026
Choose Embody if you want a straightforward compounded injection with the lower published one-month commitment.
Compounded semaglutide · 12-month plan · $828 up front · checked Oct 16
Check price for EmbodyOn Embody's site · partner link
$149.99/mo equivalent at Ivim Health
Microdose semaglutide on a 4- or 6-month plan including program fee · confirm upfront total
See prices and terms for Ivim HealthThese two prices are different kinds of bill, so read the line under each price before you compare them.
Embody pays us a commission through our links. IVIM Health is included as an editorial comparison and does not currently pay us through this site. That difference does not set scores or decide which care model fits a reader. How we make money
Choose Embody if you want a straightforward compounded injection with the lower published one-month commitment. It lists one-month semaglutide at $79 and tirzepatide at $129, including care and shipping. Choose IVIM Health if a clinician-supervised microdose program is your specific goal. IVIM's lowest published microdose semaglutide rate is $75 per month on a four- or six-month term, plus a separate $74.99 monthly program fee, for a $149.99 monthly equivalent. These are different doses and care models, not interchangeable price quotes. IVIM also offers separate brand-name and oral treatment paths.
Our pick for a lower one-month cash-pay entry
Embody lists one month of compounded semaglutide at $79 and tirzepatide at $129, with medication, clinical review, coaching and shipping included.
Treatment requires clinical approval. The medication is compounded and not FDA approved, and payments are normally non-refundable after checkout.
Choose IVIM for a dedicated lower-dose program
IVIM publishes two-, four- and six-month microdose programs with a video consultation, individualized plan, weekly check-ins and app access.
Its $75 medication floor excludes the separate $74.99 monthly program fee and requires a four- or six-month term. Microdosing is not proven equivalent to standard-dose treatment.
Sources: Embody current product catalogue · IVIM Health microdosing programs and prices · FDA questions and answers on compounded drugs
| Embody | Ivim Health | |
|---|---|---|
| Price | from $69/mo | $149.99/mo equivalentMicrodose semaglutide on a 4- or 6-month plan including program fee; confirm upfront total |
| Medicine | Compounded only | Brand-name and compounded |
| Needle-free option | Not listed | Yes, a pill or other oral form |
| Insurance | No insurance listed | Accepts insurance |
| Consultation | Included | Included (bi-weekly check-ins) |
| Shipping | Free | Included |
| Where it ships | 49 states plus DC, all except Louisiana | Not stated |
| Trustpilot | 3.8 / 5 across 10,100 reviews | Not tracked |
| BBB rating | D+ (not accredited) | Not tracked |
| Our score | 7.6/10 Good | 7.9/10 Assessment unavailable |
| Assessment limits | Checked Oct 16, 2026; a rating claim didn't match Trustpilot. | No current assessment record is available for a score comparison. This does not establish the quality of care. |
These are published terms, not a quote for your prescription. How our links work.
The reviewed injection catalogue publishes four plan lengths and their prices for both molecules. Separate promotions and the published terms do not consistently describe the same offer, so confirm the applicable commitment and renewal before paying.
Payments are normally non-refundable; a limited medical-disqualification exception applies.
Embody's $69 is not a flat price at checkout. Its public catalogue charges $79/$129 for one month, or $69/$119 a month when you prepay twelve months ($828/$1,428). A separate promotion advertises $69/$119 flat monthly, and its terms dated April 24 still list other introductory and fixed-price programs. Embody doesn't say which of these sets your first charge and renewal, so ask before you pay. Sources checked October 16, 2026.
We checked Embody's prices on September 20, 2026.Embody official pricing source
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
Want Embody on its own? Read our Embody GLP-1 review to see what you pay for semaglutide or tirzepatide and what customer reviews say, or check is Embody legit for its BBB, Trustpilot and FDA records.
Microdose programs offer two-, four- and six-month terms. Medication pricing and the separate $74.99 monthly program fee must both be included in the budget.
Microdose semaglutide from $149.99/mo equivalent: $75 medication on a four- or six-month program plus the $74.99 monthly program fee. Other protocols, medications and terms cost more; confirm the full commitment.
We checked Ivim Health's prices on September 10, 2026.Ivim Health official pricing source
Embody has the lower published one-month entry. Its catalogue lists one month of compounded semaglutide at $79 and tirzepatide at $129, including medication, clinical review, coaching and shipping. Twelve-month prepayment lowers the monthly equivalents to $69 and $119, but requires $828 or $1,428 up front. Start with the one-month figure when comparing the smallest commitment.
IVIM's microdose page lists semaglutide medication at $75 per month on four- or six-month programs and $100 per month on a two-month program. Its separate $74.99 monthly program fee brings those published monthly equivalents to $149.99 or $174.99. Microdose tirzepatide is listed at $133 per month on six months, $150 on four months or $200 on two months. With the program fee, the corresponding monthly equivalents are $207.99, $224.99 and $274.99.
IVIM presents these as monthly program amounts, but the public page does not settle every shopper's charge timing. Confirm the total due today, renewal date and full term before paying. A microdose price also cannot be treated as a quote for a standard-dose prescription.
Sources:Embody catalogue and plan terms· Embody plan-by-plan pricing· IVIM microdose price grid and program fee
Embody is the more direct match for a cash-paying shopper seeking a conventional compounded semaglutide or tirzepatide injection program. A clinician reviews the intake after checkout and decides whether a compounded prescription is appropriate. Embody's current catalogue does not publish a dedicated microdose tier.
IVIM markets its microdose program to people seeking a lower-dose start, weight-maintenance support or a more individualized dosing plan. That positioning is not evidence that microdosing works as well as an approved dose schedule or is safer for a particular patient. No large randomized weight-loss trial has established those outcomes for the commercial microdose protocols described here.
If microdosing is not the actual treatment goal, do not pay a longer-term program fee merely because the medication-only number looks low. Ask the clinician which molecule, dose and schedule fit your medical history first, then compare the complete price for that specific path.
Sources:Embody program and clinical review· IVIM explanation of its microdose program· GLP-1 Picks microdosing evidence guide
Embody's current catalogue is narrower. It lists compounded semaglutide and tirzepatide injections, with clinician review, coaching, messaging support, dose oversight and delivery in the program. It does not currently list an oral GLP-1 or an FDA-approved brand-name option.
IVIM has the broader treatment menu. Its microdose program includes a video consultation, individualized plan, weekly support, app access and other coaching features. Separate IVIM pathways advertise the brand-name Wegovy pill, Foundayo pill and brand-name injections. Those products have their own eligibility, dose and pricing structures, so their prices should not be substituted for the microdose-program totals above.
Choose breadth only when you need it. IVIM is more useful if you want to discuss lower-dose, oral and brand-name routes through one platform. Embody is simpler if a cash-pay compounded injection is already the agreed treatment path.
Sources:Embody current products and included care· IVIM microdose care features· IVIM Wegovy pill program· IVIM Foundayo pill program
Embody says the subscription begins when payment is made, before the clinician has completed the prescribing decision. Its policy makes paid plans normally non-refundable. If Embody's provider determines that you are medically disqualified, unused services may be refunded after services already provided are deducted. Other cancellations stop future billing and must reach support at least 72 hours before the next charge.
IVIM says an active membership is required for its medication program and that paying does not guarantee a prescription. Its returns policy says prescribed medication is nonreturnable and non-refundable. Its terms describe a possible refund for undelivered medication when ending a program early, less $100 for each undelivered three-month portion or $50 for each undelivered two-month portion; those fees are waived when IVIM determines medical ineligibility.
For either program, save the exact checkout terms. Confirm what is charged before clinical review, which amount is refundable if you do not qualify, and whether a longer term is paid monthly or in advance.
Sources:Embody refund and cancellation policy· IVIM medication-program terms· IVIM returns and refund policy
Strengths
More to watch for
Strengths
Compounded medicines are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. Read the FDA's explanation of the risks.
Embody has the lower published one-month cash-pay entry: $79 for compounded semaglutide or $129 for tirzepatide, including care and shipping.
No. IVIM lists a separate $74.99 monthly program fee.
IVIM offers separate brand-name oral pathways for Wegovy pill and Foundayo.
No. Compounded semaglutide and tirzepatide are not FDA-approved finished products and are not generic versions of approved brands.
Start with Embody if a clinician-supported compounded injection is your intended path and you want the lower one-month commitment.
Embody:prices checked September 20, 2026, score evidence assessed October 16, 2026.Read our Embody review
Ivim Health:prices checked September 10, 2026, score evidence assessed September 3, 2026.Ivim Health pricing and sources
We score on a published methodology, and partnership never changes a score or a fact here.
Before you sign up, read our trust check: is Embody legit.
Embody reviewIvim Health prices and sourcesAll comparisonsFind your match